Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition

por Kudura, Ken, Ritz, Nando, Templeton, Arnoud J., Kutzker, Tim, Foerster, Robert, Antwi, Kwadwo, Kreissl, Michael C., Hoffmann, Martin H. K.
Publicado 2023

Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors

por Kudura, Ken, Ritz, Nando, Kutzker, Tim, Hoffmann, Martin H. K., Templeton, Arnoud J., Foerster, Robert, Kreissl, Michael C., Antwi, Kwadwo
Publicado 2022

Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival

por Kudura, Ken, Ritz, Nando, Templeton, Arnoud J., Kissling, Marc, Kutzker, Tim, Foerster, Robert, Hoffmann, Martin H. K., Antwi, Kwadwo, Kreissl, Michael C.
Publicado 2023

An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data

por Kudura, Ken, Ritz, Nando, Templeton, Arnoud J., Kutzker, Tim, Hoffmann, Martin H. K., Antwi, Kwadwo, Zwahlen, Daniel R., Kreissl, Michael C., Foerster, Robert
Publicado 2023

Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report

por Ercan, Caner, Coto-Llerena, Mairene, Gallon, John, Fourie, Lana, Marinucci, Mattia, Hess, Gabriel F., Vosbeck, Jürg, Taha-Mehlitz, Stephanie, Boldanova, Tuyana, Meier, Marie-Anne, Tzankov, Alexandar, Matter, Matthias S., Hoffmann, Martin H. K., Di Tommaso, Luca, von Flüe, Markus, Ng, Charlotte K. Y., Heim, Markus H., Soysal, Savas D., Terracciano, Luigi M., Kollmar, Otto, Piscuoglio, Salvatore
Publicado 2022